Metastatic Breast Cancer: Bevacizumab Slows Progression, But Has No Impact On Surviva
The cancer drug bevacizumab (AvastinĀ®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers...